|
|
| Line 3: |
Line 3: |
| | <StructureSection load='6umx' size='340' side='right'caption='[[6umx]], [[Resolution|resolution]] 2.79Å' scene=''> | | <StructureSection load='6umx' size='340' side='right'caption='[[6umx]], [[Resolution|resolution]] 2.79Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[6umx]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UMX OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6UMX FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6umx]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UMX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6UMX FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.79Å</td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MSTN, GDF8 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6umx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6umx OCA], [http://pdbe.org/6umx PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6umx RCSB], [http://www.ebi.ac.uk/pdbsum/6umx PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6umx ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6umx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6umx OCA], [https://pdbe.org/6umx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6umx RCSB], [https://www.ebi.ac.uk/pdbsum/6umx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6umx ProSAT]</span></td></tr> |
| | </table> | | </table> |
| | == Disease == | | == Disease == |
| - | [[http://www.uniprot.org/uniprot/GDF8_HUMAN GDF8_HUMAN]] Myostatin-related muscle hypertrophy. The disease is caused by mutations affecting the gene represented in this entry. | + | [https://www.uniprot.org/uniprot/GDF8_HUMAN GDF8_HUMAN] Myostatin-related muscle hypertrophy. The disease is caused by mutations affecting the gene represented in this entry. |
| | == Function == | | == Function == |
| - | [[http://www.uniprot.org/uniprot/GDF8_HUMAN GDF8_HUMAN]] Acts specifically as a negative regulator of skeletal muscle growth. | + | [https://www.uniprot.org/uniprot/GDF8_HUMAN GDF8_HUMAN] Acts specifically as a negative regulator of skeletal muscle growth. |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 21: |
Line 21: |
| | </div> | | </div> |
| | <div class="pdbe-citations 6umx" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6umx" style="background-color:#fffaf0;"></div> |
| | + | |
| | + | ==See Also== |
| | + | *[[Growth differentiation factor 3D STRUCTURES|Growth differentiation factor 3D STRUCTURES]] |
| | + | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| - | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Bostion, C J]] | + | [[Category: Bostion CJ]] |
| - | [[Category: Capili, A D]] | + | [[Category: Capili AD]] |
| - | [[Category: Carven, G J]] | + | [[Category: Carven GJ]] |
| - | [[Category: Dagbay, K B]] | + | [[Category: Dagbay KB]] |
| - | [[Category: Faucette, R R]] | + | [[Category: Faucette RR]] |
| - | [[Category: Jackson, J W]] | + | [[Category: Jackson JW]] |
| - | [[Category: Lin, S C]] | + | [[Category: Lin SC]] |
| - | [[Category: Nicholls, S B]] | + | [[Category: Nicholls SB]] |
| - | [[Category: Nikiforov, A]] | + | [[Category: Nikiforov A]] |
| - | [[Category: Streich, F C]] | + | [[Category: Streich Jr FC]] |
| - | [[Category: Treece, E]] | + | [[Category: Treece E]] |
| - | [[Category: Antibody]]
| + | |
| - | [[Category: Fab]]
| + | |
| - | [[Category: Gdf8]]
| + | |
| - | [[Category: Muscle wasting disease]]
| + | |
| - | [[Category: Myostatin]]
| + | |
| - | [[Category: Signaling protein-immune system complex]]
| + | |
| - | [[Category: Transforming growth factor beta]]
| + | |
| Structural highlights
Disease
GDF8_HUMAN Myostatin-related muscle hypertrophy. The disease is caused by mutations affecting the gene represented in this entry.
Function
GDF8_HUMAN Acts specifically as a negative regulator of skeletal muscle growth.
Publication Abstract from PubMed
Myostatin (or growth/differentiation factor 8 [GDF8]) is a member of the transforming growth factor beta (TGF-beta) superfamily of growth factors and negatively regulates skeletal muscle growth. Its dysregulation is implicated in muscle wasting diseases. SRK-015 is a clinical-stage monoclonal antibody that prevents extracellular proteolytic activation of pro- and latent myostatin. Here, we used integrated structural and biochemical approaches to elucidate the molecular mechanism of an antibody-mediated neutralization of pro-myostatin activation. The crystal structure of pro-myostatin in complex with 29H4-16 Fab, a high-affinity variant of SRK-015, at 2.79 A resolution revealed that the antibody binds to a conformational epitope in the arm region of the prodomain distant from the proteolytic cleavage sites. This epitope is highly sequence divergent, sharing only limited similarity to other closely related members of the TGF-beta superfamily. Hydrogen/deuterium exchange-MS experiments indicated that antibody binding induces conformational changes in pro- and latent myostatin that span the arm region, the loops contiguous to the protease cleavage sites, and the latency-associated structural elements. Moreover, negative-stain EM with full-length antibodies disclosed a stable, ring-like antigen-antibody structure in which the two Fab arms of a single antibody occupy the two arm regions of the prodomain in the pro- and latent myostatin homodimers, suggesting a 1:1 (antibody:myostatin homodimer) binding stoichiometry. These results suggest that SRK-015 binding stabilizes the latent conformation and limits the accessibility of protease cleavage sites within the prodomain. These findings shed light on approaches that specifically block the extracellular activation of growth factors by targeting their precursor forms.
Structural basis for specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015.,Dagbay KB, Treece E, Streich FC Jr, Jackson JW, Faucette RR, Nikiforov A, Lin SC, Boston CJ, Nicholls SB, Capili AD, Carven GJ J Biol Chem. 2020 Feb 19. pii: RA119.012293. doi: 10.1074/jbc.RA119.012293. PMID:32075906[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Dagbay KB, Treece E, Streich FC Jr, Jackson JW, Faucette RR, Nikiforov A, Lin SC, Boston CJ, Nicholls SB, Capili AD, Carven GJ. Structural basis for specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015. J Biol Chem. 2020 Feb 19. pii: RA119.012293. doi: 10.1074/jbc.RA119.012293. PMID:32075906 doi:http://dx.doi.org/10.1074/jbc.RA119.012293
|
